Risk Factors for Histologic Chorioamnionitis Among Women with Prenatal Fever During Preterm Delivery: A Retrospective Cohort Study

Nan Lin, Yiru Shi, Yuanqing Xia, Yunfan Yang, Renyi HuaInternational Journal of Women s Health 2025 · DOI

TL;DR

This study identifies critical clinical markers—specifically a maternal white blood cell (WBC) count $\ge 11 \times 10^9/L$ and a prolonged interval between membrane rupture and fever—to predict histologic chorioamnionitis (HCA) in preterm deliveries. These findings provide obstetricians with evidence-based thresholds to balance the risks of neonatal infection against the benefits of prolonging a preterm pregnancy.

What Problem Does This Paper Address?

Obstetricians often face a high-stakes dilemma in preterm pregnancies: expectant management (waiting to allow the fetus to mature) versus active intervention (inducing delivery to avoid infection).

The culprit is often Chorioamnionitis (CAM), an inflammation of the fetal membranes. While "clinical" CAM presents with obvious symptoms like high fever and foul discharge, Histologic Chorioamnionitis (HCA)—diagnosed by examining the placenta after birth—is frequently "silent" or subclinical. HCA is a major driver of neonatal sepsis, cerebral palsy, and respiratory distress. Because HCA can only be definitively diagnosed post-delivery, clinicians need reliable "proxy" biomarkers to decide when the risk of staying in the womb outweighs the risk of being born early.

Methods

The researchers conducted a retrospective cohort study of 220 women who delivered preterm (28 to 36+6 weeks) and experienced prenatal fever at a tertiary hospital in Shanghai between 2018 and 2020.

The cohort was split into two groups based on placental pathology: an HCA group (101 cases) and a control group (119 cases). The team utilized:

  • Multiple Logistic Regression: To control for confounders like maternal age, BMI, and gestational hypertension.
  • ROC (Receiver Operating Characteristic) Curves: To determine the optimal "cutoff" values for inflammatory biomarkers.
  • Correlation Analysis: To examine the relationship between maternal and neonatal C-reactive protein (CRP) levels.

Datasets

The study relied on a clinical dataset from the International Peace Maternity and Child Health Hospital in Shanghai. It included:

  • 220 singleton preterm live births.
  • Comprehensive electronic medical records (maternal age, BMI, WBC counts, CRP levels, and vaginal microbiology).
  • Standardized placental pathology results (the "gold standard" for HCA diagnosis).

Key Insights and Ideas

  • The "Ticking Clock" of PPROM: The interval between Preterm Premature Rupture of Membranes (PPROM) and the onset of fever is a massive risk factor. If this interval exceeds 48 hours, the odds of HCA increase more than six-fold (aOR 6.201).
  • The 11-Unit Threshold: While WBC counts are standard in prenatal care, this study identifies $11 \times 10^9/L$ as the "sweet spot" for prediction. At this level, the test achieved 80% sensitivity, providing a concrete metric for clinical decision-making.
  • Neonatal Sepsis Spike: The data confirms a stark reality: neonates in the HCA group were nearly ten times more likely to suffer from sepsis compared to the control group.
  • The Role of Ureaplasma: The presence of Ureaplasma urealyticum in vaginal secretions was significantly higher in the HCA group (28.57% vs 16.07%), suggesting that specific microbial colonization plays a heavy role in triggering the inflammatory cascade.

Key Results

  • Neonatal Outcomes: Neonatal sepsis occurred in 8.89% of HCA cases compared to only 0.90% in the control group ($P=0.017$). Congenital infection was also significantly higher (27.66% vs 15.38%).
  • Predictive Power: A maternal WBC count $\ge 11 \times 10^9/L$ demonstrated an Area Under the Curve (AUC) of 0.667, which, while modest, provides a statistically significant discriminatory power for a subclinical condition.
  • Inflammatory Markers: Maternal CRP levels $> 10$ mg/L were also strongly associated with HCA (aOR 2.292). Interestingly, maternal and neonatal CRP levels showed a significant positive correlation ($r=0.183, P=0.010$).

Limitations and Future Work

The authors acknowledge several constraints:

  1. Single-Center Design: The findings are based on one hospital in Shanghai, which may limit generalizability to other regions or different clinical practices.
  2. Retrospective Nature: The study can identify associations but cannot definitively establish a causal relationship between the markers and the infection.
  3. Fever-Only Inclusion: The study only looked at women who already had a fever. Since HCA can occur without fever, future research is needed to identify biomarkers in asymptomatic pregnant women.
  4. Future Directions: The researchers suggest that implementing rapid, point-of-care testing for inflammatory markers in labor units could further improve real-time decision-making and neonatal outcomes.

Summary updated

Abstract

HCA significantly increases the risks of neonatal sepsis and congenital infection in preterm infants. A prolonged PPROM-fever interval (> 24 h) and a maternal WBC ≥11×10<sup>9</sup>/L are key predictive factors for the need for active obstetric intervention. This study provides evidence-based cutoff values for clinical decision-making in preterm pregnancies with fever, potentially improving maternal and neonatal outcomes through timely intervention.
BibTeX
@article{lin2025risk,
  author = {Nan Lin and Yiru Shi and Yuanqing Xia and Yunfan Yang and Renyi Hua},
  title = {{Risk Factors for Histologic Chorioamnionitis Among Women with Prenatal Fever During Preterm Delivery: A Retrospective Cohort Study}},
  journal = {International Journal of Women s Health},
  year = {2025},
  doi = {10.2147/ijwh.s542606},
}
Figure